Displaying 253 - 264 of 275
Viral Hepatitis
5

Gilead: A NEW VIRUS IN THE MIX: Re-imagining liver disease care in the COVID-19 era - Digital ILC 2020

View
Viral Hepatitis
5

Gilead: A NEW VIRUS IN THE MIX: Re-imagining liver disease care in the COVID-19 era - Digital ILC 2020

View
Viral Hepatitis
5

Gilead: A NEW VIRUS IN THE MIX: Re-imagining liver disease care in the COVID-19 era - Digital ILC 2020

View
General Hepatology
7

Norgine: Preventing a domino effect in the management of hepatic encephalopathy - The International Liver Congress™ 2019

View
General Hepatology
7

Norgine: Preventing a domino effect in the management of hepatic encephalopathy - The International Liver Congress™ 2019

View
General Hepatology
7

Norgine: Preventing a domino effect in the management of hepatic encephalopathy - The International Liver Congress™ 2019

View
General Hepatology
7

Norgine: Preventing a domino effect in the management of hepatic encephalopathy - The International Liver Congress™ 2019

View
General Hepatology
7

Norgine: Preventing a domino effect in the management of hepatic encephalopathy - The International Liver Congress™ 2019

View
General Hepatology
7

Norgine: Preventing a domino effect in the management of hepatic encephalopathy - The International Liver Congress™ 2019

View
General Hepatology
7

Norgine: Preventing a domino effect in the management of hepatic encephalopathy - The International Liver Congress™ 2019

View
Cirrhosis & Complications
4

Grifols: Albumin: a disease-modifying agent in decompensated cirrhosis - Digital ILC 2020

View
Cirrhosis & Complications
4

Grifols: Albumin: a disease-modifying agent in decompensated cirrhosis - Digital ILC 2020

View
Displaying 253 - 264 of 275